logo-loader
viewHeritage Cannabis Holdings Corp.

Heritage Cannabis subsidiary Endocanna Health launches EndoDNA test kit in Canada

The test helps individuals to pick more personalized cannabis products and help them choose formulation, dosage and the best delivery method for their unique needs

dna cannabis
The Test Kit analyzes hundreds of genes and over 550,000 single nucleotide polymorphisms in humans

Heritage Cannabis Holdings Corp (CSE:CANN) (OTCMKTS:HERTF) launched its EndoDNA Test Kit in Canada on Wednesday through its partly owned subsidiary Endocanna Health Inc.

The Test Kit analyzes hundreds of genes and over 550,000 single nucleotide polymorphisms in humans to generate a personalized report showing how a person’s genetic makeup is affected by cannabinoids and terpenes.

The report will help individuals to pick more personalized cannabis products and help them choose formulation, dosage and the best delivery method for their own needs.

READ: Empower Clinics inks strategic tie-up with Endocanna Health to sell endocannabinoid DNA test kits

"With millions of cannabis consumers coming into the new legal market each year, EndoDNA aims to bring confidence through education, and to guide cannabis consumers to an optimal health and wellness experience,” said Len May, Endocanna’s CEO.

EndoDNA aims to give consumers a scientific alternative to trial-and-error selection or crowd-sourced buying, May told shareholders.

"Everyone has a unique response to THC, CBD and all other cannabinoids; no two people will have the same exact experience,” May said. “This makes it particularly challenging for new consumers with finding the right product for their specific needs.”

The kits will be available for purchase online and can submit a saliva swap for analysis. Users may also be able to use reports generated from other DNA testing kits to upload their raw data to the EndoDNA test.

Heritage CEO Clint Sharples said the launch of EndoDNA in Canada is part of the parent company’s wider strategy to utilize science to expand the company’s medical offerings in the country.

"We are excited to bring EndoDNA to Canada and to provide individuals with the tools, resources, and most up-to-date science and research available, to make confident, smart decisions when incorporating cannabis into their lives,” Sharples said in a statement.

Heritage holds a 30% state in Endocanna Health Inc.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Quick facts: Heritage Cannabis Holdings Corp.

Price: 0.3 CAD

CSE:CANN
Market: CSE
Market Cap: $142.09 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Heritage Cannabis Holdings Corp. named herein, including the promotion by the Company of Heritage Cannabis Holdings Corp. in any Content on the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Ontario's cannabis retail expansion plan gives cannabis stocks...

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, was 1.4% higher at 116.7 points. Elsewhere, the Horizons Marijuana Life Sciences Index ETF jumped 2.4% at C$9.55, while the OTCQX Cannabis index gained 0.6% to 434 points. Buds today are The Green...

on 12/13/2019

2 min read